Clinical trial
Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease: a Randomized, Single-blind, Crossover Clinical Study
NCT04001894 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor and Clopidogrel on Platelet Effects in Chinese Patients With Stable Coronary Artery Disease: a Randomized, Single-blind, Crossover Clinical Study
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 2, 2019
- Completion date
- December 9, 2020
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
platelet reactivity